Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates as a managed services firm that supports health systems and physician organizations in migration toward value-based care and population health management. Its services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services, and comprehensive health plan administration services. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Management services
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolNYSE:EVH
Previous Symbol
CUSIPN/A
Phone571-389-6000
Debt
Debt-to-Equity Ratio0.12
Current Ratio2.50
Quick Ratio2.50
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$434.95 million
Price / Sales3.48
Cash FlowN/A
Price / Cash FlowN/A
Book Value$13.52 per share
Price / Book1.36
Profitability
EPS (Most Recent Fiscal Year)($0.70)
Net Income$-60,660,000.00
Net Margins-9.05%
Return on Equity-2.18%
Return on Assets-1.74%
Miscellaneous
Employees2,600
Outstanding Shares82,230,000
Market Cap$1.58 billion
OptionableOptionable
Evolent Health (NYSE:EVH) Frequently Asked Questions
What is Evolent Health's stock symbol?
Evolent Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVH."
How were Evolent Health's earnings last quarter?
Evolent Health Inc (NYSE:EVH) released its earnings results on Tuesday, November, 6th. The technology company reported ($0.04) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.11) by $0.07. The technology company had revenue of $150.16 million for the quarter, compared to the consensus estimate of $142.94 million. Evolent Health had a negative net margin of 9.05% and a negative return on equity of 2.18%. The company's revenue was up 38.6% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.18) EPS. View Evolent Health's Earnings History.
When is Evolent Health's next earnings date?
What price target have analysts set for EVH?
10 brokers have issued twelve-month price objectives for Evolent Health's shares. Their forecasts range from $25.00 to $37.00. On average, they expect Evolent Health's share price to reach $32.4444 in the next twelve months. This suggests a possible upside of 76.4% from the stock's current price. View Analyst Price Targets for Evolent Health.
What is the consensus analysts' recommendation for Evolent Health?
10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Evolent Health in the last year. There are currently 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Evolent Health.
What are Wall Street analysts saying about Evolent Health stock?
Here are some recent quotes from research analysts about Evolent Health stock:
- 1. According to Zacks Investment Research, "Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia. " (12/4/2018)
- 2. Cantor Fitzgerald analysts commented, ". We reiterate our Overweight rating on EVH shares and increase our price target to $37 from $28. This morning, EVH announced the acquisition of privately-held New Century Health (NCH). NCH manages approximately 462,000 Medicare Advantage lives for 12 long-term operating partners across multiple states. NCH’s customers include at-risk providers as well as national and regional health plans. We believe that the acquisition of NCH is very attractive financially and a very solid fit strategically. NCH basically doubles EVH’s adjusted EBITDA. Strategically, it looks like NCH operates a more mature" EVH business model. Overall, we believe the acquisition is a nice positive for EVH." (9/12/2018)
Has Evolent Health been receiving favorable news coverage?
Media headlines about EVH stock have trended negative recently, InfoTrie Sentiment reports. The research group rates the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Evolent Health earned a media sentiment score of -2.4 on InfoTrie's scale. They also gave news coverage about the technology company a news buzz of 5.0 out of 10, meaning that recent news coverage is somewhat likely to have an effect on the company's share price in the near term.
Who are some of Evolent Health's key competitors?
Who are Evolent Health's key executives?
Evolent Health's management team includes the folowing people:
- Mr. Frank J. Williams, Co-Founder, CEO & Chairman (Age 51)
- Mr. Seth Blackley, Co-Founder, Pres & Director (Age 39)
- Mr. Thomas Peterson III, Co-Founder & COO (Age 48)
- Mr. Nicholas McGrane, Chief Financial Officer (Age 50)
- Ms. Lydia Stone, VP, Chief Accounting Officer & Controller (Age 42)
When did Evolent Health IPO?
(EVH) raised $150 million in an initial public offering on Friday, June 5th 2015. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs served as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers.
Who are Evolent Health's major shareholders?
Evolent Health's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Capital Research Global Investors (9.72%), Vanguard Group Inc. (6.95%), Vanguard Group Inc (6.95%), Bank of New York Mellon Corp (7.01%), BlackRock Inc. (5.81%) and Riverbridge Partners LLC (4.36%). Company insiders that own Evolent Health stock include Board Co Advisory, Cheryl Scott, Frank J Williams, Jonathan Weinberg, Kenneth A Samet, Lydia Stone, Nicholas Mcgrane, Seth Blackley, Steve Wigginton, Thomas Peterson III, Tpg Growth Ii Advisors, Inc, Unitedhealth Group Inc and Upmc. View Institutional Ownership Trends for Evolent Health.
Which institutional investors are selling Evolent Health stock?
EVH stock was sold by a variety of institutional investors in the last quarter, including Gabelli Funds LLC, Riverbridge Partners LLC, Pictet Asset Management Ltd., Elk Creek Partners LLC, Peregrine Capital Management LLC, Bank of New York Mellon Corp, Blair William & Co. IL and Credit Suisse AG. Company insiders that have sold Evolent Health company stock in the last year include Cheryl Scott, Frank J Williams, Jonathan Weinberg, Lydia Stone, Seth Blackley, Thomas Peterson III and Unitedhealth Group Inc. View Insider Buying and Selling for Evolent Health.
Which institutional investors are buying Evolent Health stock?
EVH stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC, Columbus Circle Investors, Castleark Management LLC, Vanguard Group Inc, Vanguard Group Inc., Rehmann Capital Advisory Group, Standard Life Aberdeen plc and Standard Life Aberdeen plc. View Insider Buying and Selling for Evolent Health.
How do I buy shares of Evolent Health?
Shares of EVH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Evolent Health's stock price today?
One share of EVH stock can currently be purchased for approximately $18.39.
How big of a company is Evolent Health?
Evolent Health has a market capitalization of $1.58 billion and generates $434.95 million in revenue each year. The technology company earns $-60,660,000.00 in net income (profit) each year or ($0.70) on an earnings per share basis. Evolent Health employs 2,600 workers across the globe.
What is Evolent Health's official website?
How can I contact Evolent Health?
Evolent Health's mailing address is 800 NORTH GLEBE RD SUITE 500, ARLINGTON VA, 22203. The technology company can be reached via phone at 571-389-6000.
MarketBeat Community Rating for Evolent Health (NYSE EVH)
MarketBeat's community ratings are surveys of what our community members think about Evolent Health and other stocks. Vote "Outperform" if you believe EVH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EVH will underperform the S&P 500 over the long term. You may vote once every thirty days.
